Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Κατάταξη σε μετοχές #19166
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Τιμή μετοχής
$1.62
Τελευταίος συγχρονισμός: 2026-08-25
Κεφαλαιοποίηση
$172.47M
Αλλαγή (1 ημέρα)
-3.57%
Αλλαγή (1 έτος)
446.74%
Χώρα
US
Εμπόριο Cypherpunk Technologies Inc. (CYPH)

Κατηγορία

Ιστορικό τιμής μετοχής για την Cypherpunk Technologies Inc. (CYPH)
Υψηλότερη τιμή κλεισίματος: $0.94 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $75.65 στις 2017-01-01
Ιστορικό τιμής μετοχής της Cypherpunk Technologies Inc. από 2017 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$771.23 7.19%
CH